EClinCloud Attends the 2025 Ningbo Biopharmaceutical Industry Development Conference

On December 5–6, themed "Surging East China Sea, Pharma Shaping the Future: Ningbo Biopharmaceuticals Advancing Toward the 15th Five-Year Plan," the 4th China–Ningbo Biopharmaceutical Industry Development Conference was held in Ningbo Qianwan New Area. Organized by Hangzhou Bay Life Science Park (BioVillage), the conference was chaired by Zhao Yufen, Member of the Chinese Academy of Sciences and Dean of the Institute of New Drug Technology at Ningbo University, who delivered the opening remarks. The event featured 8 major tracks and attracted nearly 1,000 attendees.
As a key contributor in clinical-research digitalization, EClinCloud was invited to attend the conference and presented its digital and intelligent clinical-research achievements. At the conference's AI in Pharma/Healthcare session, Zhang Ji, Senior Product Consultant at EClinCloud, delivered a keynote presentation titled "Current Practical Applications of LLMs in Digital Clinical Trial Systems," sharing professional perspectives on the application of and innovative thinking around large language models (LLMs) in clinical research.
From model capabilities to use-case value
Although AI faces numerous challenges at the clinical stage, it is rapidly expanding across every stage of new drug development—from trial participant recruitment and data management to endpoint assessment and efficacy prediction—and has the potential to reshape the overall efficiency and quality of clinical research.
In clinical research, algorithms, data, and computing power are the core elements of AI development, while aligning and implementing models, technologies, and use cases is the key to truly unlocking the value of AI.
Examples of AI applications
In practice, current typical application outcomes of AI in EClinCloud's digital clinical systems include:
Document intelligence: AI-based automated form entry and intelligent archiving, enabling automated EDC study build and complex document parsing, among others;
Image intelligence: applied to intelligent eCOA QC, significantly improving data review accuracy;
Data intelligence: such as intelligent distribution anomaly detection and multivariate correlation analysis, supporting clinical data quality monitoring and insight optimization.
Through the integration of AI algorithms, computing power, and data, EClinCloud continues to build an integrated cloud platform covering the full clinical trial lifecycle, enabling intelligent collaboration from data capture to quality analysis and advancing high-quality clinical research.
At the conference, the EClinCloud booth drew broad interest from pharmaceutical companies, CROs, and research institutions, and the team held in-depth discussions with various partners on the practical implementation of AI in clinical research.


